Publication | Open Access
Nivolumab versus chemotherapy in advanced esophageal squamous cell carcinoma (ESCC): The phase III ATTRACTION-3 study
14
Citations
0
References
2019
Year
Esophageal CancerMedicineNivolumab Versus ChemotherapyPathologyCancer TreatmentOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!